Systematic review on CUL5's role in cancer cell therapies and modulation strategies
Cancer cell therapy may get stronger by targeting a key protein
This systematic review synthesizes evidence on CUL5-mediated ubiquitination in cancer. It finds CUL5 influences tumor pathways and can enhan…
A protein called CUL5 helps control tumor growth and could be a new target to make cancer cell therapies work better.
Chemotherapy-related renal injury incidence and risk factors in patients with malignant tumors
Kidney injury risk rises with age, diabetes, and certain chemo drugs
This retrospective cohort study of 152 patients with malignant tumors found an 18.42% incidence of chemotherapy-related renal injury (CRI). …
A study of cancer patients found nearly 1 in 5 developed kidney injury after chemotherapy, with older age and diabetes among key risk factor…
Survey finds 94% of cancer patients willing to try acupuncture for symptom relief
What do cancer patients want from acupuncture? A survey reveals their top hopes.
A questionnaire survey of 511 cancer patients at Beijing Cancer Hospital found 481 (94.1%) were willing to receive acupuncture treatment. Di…
Cancer patients overwhelmingly want acupuncture to help with sleep, pain, and fatigue, with 94% expressing willingness to try the treatment.